News

Benefit of lumbar fusion for spinal stenosis found to be small to nonexistent

View on the News

Fusion no longer best practice

Both of these studies clearly demonstrated that for most patients, stenosis surgery should be limited to decompression when no overt instability is present. Dr. Ghogawala and his colleagues correctly concluded that the modest difference in SF-36 score in favor of fusion doesn’t justify that procedure’s higher cost and complication rate.

Fusion surgery is no longer best practice and should be restricted to patients who have proven spinal instability; vertebral destruction caused by trauma, tumors, infections, or spinal deformities; or possibly neuroforamen stenosis with compressed exiting nerves due to postsurgical disk collapse.

Dr. Wilco C. Peul is at Leiden (the Netherlands) University Medical Center and at Medical Center Haaglanden, the Hague. Dr. Wouter A. Moojen is at Medical Center Haaglanden. Dr. Peul reported receiving grants from ZonMW, Paradigm Spine, Medtronic, Eurospine Foundation, and CVZ. Dr. Moojen reported having no relevant financial disclosures. Dr. Peul and Dr. Moojen made these remarks in an editorial accompanying the reports on the Swedish Spinal Stenosis Study and the Spinal Laminectomy Versus Instrumented Pedicle Screw trial (N Engl J Med. 2016 April 13. doi: 10.1056/NEJMe1600955).


 

FROM THE NEW ENGLAND JOURNAL OF MEDICINE

At 2 years, patients in the fusion group showed a small but significant advantage of 5.7 points on the SF-36, with a mean score of 15.2, compared with patients in the decompression-only group (mean score, 9.5). However, the ODI scores, a secondary outcome measure in this study, were not significantly different between the two study groups, Dr. Ghogawala and his associates reported (N Engl J Med. 2016 April 13. doi: 10.1056/NEJMoa1508788).Surgical complications, blood loss, and length of stay all were significantly greater with fusion than with decompression alone.

Dr. Försth’s study was supported by Uppsala University, Uppsala County Council, the Stockholm Spine Center, and Johnson & Johnson. Two of his associates reported ties to Medtronic and Quantify Research. Dr. Ghogawala’s study was supported by the Jean and David Wallace Foundation, the Greenwich Lumbar Stenosis SLIP Study Fund. His associates reported ties to numerous industry sources.

Pages

Recommended Reading

Acetaminophen ineffective against osteoarthritis pain
MDedge Rheumatology
ACR’s 2016-2020 research agenda built through consensus
MDedge Rheumatology
Finding the right path for pain control
MDedge Rheumatology
Mindfulness, cognitive therapy top conventional care for low back pain
MDedge Rheumatology
FDA requires boxed warnings for short-acting opioids
MDedge Rheumatology
Long-term antibiotics ineffective for persistent Lyme disease
MDedge Rheumatology
Carpal tunnel syndrome: Guidelines rate evidence for diagnosis, treatment
MDedge Rheumatology
Persistent knee pain predicts structural osteoarthritis early
MDedge Rheumatology
Addiction – how are we being played?
MDedge Rheumatology
Small fiber neuropathy common, vexing in sarcoidosis
MDedge Rheumatology